DOCSLIB.ORG

Podoscopio N79.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Podoscopio N79.Indd 1ª Época VOL. 1 Nº 79 4o Trimestre de 2018 CUIDADOS Y ACTUALIZACIÓN EN EL ABORDAJE TERAPÉUTICO DE LA PSORIASIS DESCRIPCIÓN CLÍNICO-EPIDEMIOLÓGICA DE LOS TUMORES MALIGNOS DE ORIGEN MELANOCÍTICO (MELANOMAS) Sumario 79.pdf 1 4/1/19 9:24 Revista Podoscopio 1ª ÉPOCA VOL. 1_ Nº 79 4o Trimestre de 2018 Director Dr. Pedro Villalta García Sumario Coordinador de Redacción Luis Monterrubio Adánez Edita Junta de Gobierno del Colegio de Podólogos Editorial de la Comunidad de Madrid 1886_ San Bernardo, 74 bajo izqda. 28015-Madrid Telf.: 91 532 60 06 Cuidados y actualización en el abordaje Fax: 91 522 87 63 1887_ terapéutico de la psoriasis Correo electrónico: copoma@copoma.es > BEATRIZ HERNÁNDEZ BLANCO Web: www.copoma.es Junta de Gobierno Decano Descripción clínico-epidemiológica de los Dr. Pedro Villalta García 1914_ tumores malignos de origen melanocítico Vicedecano Luis Soler Mínguez (melanomas) Secretaria > JOSÉ VALERO Gema López García > NURIA SARROCA Tesorera > DAVID GONZÁLEZ Mª Montserrat Gómez Maya > JOSÉ GALLART Vocales Luis Monterrubio Adánez Natalia Fernández Ospina Juan Carlos Montero Arroyo Patrocinio Olmo Serna 1924_ Normas de publicación Manuel Meneses Garde Comisión Científica Comisión de Recursos Dr. Pedro Villalta García Presidente Francisco Matías Martín Luis Monterrubio Adánez Vicepresidente Natalia Fernández Ospina Félix Romeral Bravo Secretario Gregorio Díaz Tadeo Depósito Legal: M-42451-1983 ISSN: 0212-7393 Imprime: Copysell, S. L. Esta publicación está considerada como soporte válido para información de especialidades farmacéuticas, a tenor de lo dispuesto en el Capítulo VII del Real Decreto 3451/77, del 1 de diciembre. Referencia SVR, nº 383. La dirección se reserva la libertad de aceptar o no los trabajos enviados, y no asume la responsabilidad de los artículos firmados. Revista del Colegio de Podólogos de la Comunidad de Madrid PODOSCOPIO EDITORIAL Estimado/a compañero/a El nuevo año 2019 nos espera con multitud de proyectos y avances nuevos para desarrollar nuestra profesión El día 4 de diciembre se ha publicado la Consideramos que la reciente orden aproba- Orden 1158/2018, de 7 de noviembre, da, no desarrolla completamente todas las del Consejero de Sanidad, por la que competencias de la profesión podológica, am- se regulan los requisitos técnicos parada en la Orden CIN/728/2009, de marzo, generales y específicos de los centros y servicios por la que se establecen los requisitos para sanitarios sin internamiento, de los servicios la verificación de los títulos universitarios sanitarios integrados en una organización no oficiales que habiliten para el ejercicio de la sanitaria y de la asistencia sanitaria prestada podología, ya que en el módulo denominado por profesionales sanitarios a domicilio en “Quiropodología y Cirugía Podológica” tiene la Comunidad de Madrid, en ella, se regula como competencias “Conocer y obtener habi- la Unidad de Podología (U.4), donde nos lidades en la aplicación de las técnicas podoló- especifica las áreas diferenciadas para nuestra gicas de cirugía ungueal, de cirugía podológica actividad podológica, mejorando con respecto de partes blandas, de cirugía ósea y articular a la normativa del 31 de mayo de 2010. del pie”, igualmente en el apartado 3, punto 1. “Conocer y aplicar los fundamentos teóricos En esta orden nos especifica al área clínica para y metodológicos de la Podología y Podiatria”. quiropodología, de exploración biomecánica que podrá estar unida al área de exploración También en este mes de diciembre, la Real cuyas dimensiones sean de 10 m2, de ortopo- Academia Española de la Lengua, ha admitido dología, donde podremos realizar las plantillas dentro de la definición de “doctor, ra. m y para el tratamiento de nuestros pacientes que f. Médico u otro profesional especializado en así los diagnostiquemos, y área quirúrgica que alguna técnica terapéutica, como el dentista, bajo anestesia local y que no requieran cuida- el podólogo, etc. U. frec. como tratamiento”. dos postoperatorios podrán realizarse en las Por tal motivo, debemos estar orgullosos de clínicas, aunque en caso de requerir cuidados la nueva aceptación para la podología. postoperatorios de corta duración y no requie- El nuevo año 2019 nos espera con multitud de ran ingreso hospitalario, deberán realizarse en proyectos y avances nuevos para desarrollar las unidades de cirugía mayor ambulatoria, así nuestra profesión, uno de ellos, será continuar como regula la asistencia podológica domicilia- con la reivindicación de la inclusión de la po- ria y la sedación consciente por parte del profe- dología en la sanidad pública en atención y sional de la podología. tratamiento del pie diabético. 1886_ Podoscopio 2018; 4 (79): 1886 Revista del Colegio de Podólogos de la Comunidad de Madrid Cuidados y actualización en el abordaje terapéutico de la Psoriasis PODOSCOPIO Cuidados y actualización en el abordaje terapéutico de la psoriasis > Beatriz Hernández Blanco. Grado en Podología por la Universidad Alfonso X El Sabio. 1 RESUMEN: el tema. Siendo los criterios de exclusión los siguientes: otros idiomas que no sean inglés, La psoriasis es una enfermedad inflamatoria artículos que no sean sobre bases científicas, crónica de la piel de etiología desconocida que tratamientos aplicados en población con enfer- tiene repercusión en el pie. Presenta una gran medad de base, anteriores al año 2009, artículos variedad de tratamientos, aunque no existe privados, tratamientos realizados secundarios a ninguno de elección. La elección depende de la gravedad, extensión, perfil, beneficio-ries- una enfermedad de base. go, preferencias del paciente y de la respuesta Resultados: al tratamiento. Además, es una patología re- Se analizaron los diferentes tratamientos, poso- currente y es frecuente que se requieran dife- logía, efectos adversos, eficacia, vías de adminis- rentes tratamientos para mantener la enfer- tración, indicaciones terapéuticas que se adap- medad estable. tan a los criterios de inclusión. Objetivos y metodología: Conclusión: En esta revisión bibliográfica, actualizaremos los No existe un tratamiento más eficaz que otro, el diferentes tratamientos de la psoriasis respon- tratamiento a considerar dependerá de cada pa- diendo a los siguientes objetivos: Comparar los ciente y su finalidad (adecuado para inducir re- diferentes tratamientos y sus efectos adversos misión, tratamiento de mantenimiento, acepta- para esta patología, evaluar la efectividad del ción por el paciente…etc). Así mismo la eficacia tratamiento tópico, conocer la efectividad del tratamiento sistémico, conocer la efectividad de de cada tratamiento variará según sus diferentes las terapias biológicas y estudiar los cuidados de combinaciones. higiene necesario en la psoriasis. Palabras clave: La información se adquiere de las principales Psoriais, Tratamiento sistémico, treatment fuentes y bases de datos biomédicas: dialnet, sistemic, Tratamiento tópico, topical treatment, scielo, pubmed, sapiens. Se han aceptado los terapia biológica, biologic treatment, artículos publicados en los últimos años sobre phototherapy, photochemotherapy Revista del Colegio de Podólogos de la Comunidad de Madrid Podoscopio 2018; 4 (79): 1887-1911 _ 1887 PODOSCOPIO Cuidados y actualización en el abordaje terapéutico de la Psoriasis 2 INTRODUCCIÓN: 2.1 Concepto La psoriasis es una enfermedad inflamatoria La palabra psoriasis, deriva del griego, etimoló- crónica de la piel de etiología desconocida que gicamente significa: psor. prurito, iasis: estado.8 tiene repercusión en el pie. Se caracteriza por Descrita en 1841 por Ferdinand von Hebra, es una la presencia de manifestaciones articulares y en enfermedad inflamatoria crónica de la piel, reci- la piel, ocasionando un problema importante a divante y de etiología desconocida, caracterizada nivel epidemiológico y sanitario. 1,2 por una excesiva proliferación queratinocítica. 9,4 Puede aparecer a cualquier edad, aunque mu- Presenta una clínica variable, caracterizada por chos estudios han demostrado que los brotes y pápulas y placas eritematosas, secas, de variados picos de la enfermedad aparecen en la adoles- tamaños y configuración (redondeadas, circina- cencia y también en la etapa adulta sobre los das, arcuata, serpinginosa,anular, girata,guta- 50- 60 años. 1 ta, rupoide) cubierta de escamas estratificadas, Es por prevalencia a nivel mundial, la enferme- imbricadas y abundantes, de color grisáceo o dad dermatológica con mayor tasa de afectados. blanco nacarado y de localización casi siempre Afecta a más de 100 millones de personas en simétrica) 8,9 todo el mundo con una prevalencia del 1-4%. 2,3 La variabilidad de su duración y extensión nos La psoriasis en el pie es un trastorno frecuente permitirá observar distintos grados de expresión que puede presentar una clínica variable. Las clínica 10 manifestaciones clínicas podemos clasificarlas La psoriasis no pone en riesgo la vida del pacien- en lesiones cutáneas y afectaciones ungueales. 1 te, pero puede tener un impacto psicosocial ne- La psoriasis tiene una gran variedad de trata- gativo en diferentes etapas del desarrollo de la mientos, aunque no existe ninguno de elección. vida 9,11 La elección depende de la gravedad, extensión, 2.2 Epidemiología: perfil, beneficio-riesgo, preferencias del pacien- La prevalencia de la psoriasis en adultos oscila te y de la respuesta al tratamiento. Además, es entre 0,51% y el 11,43%, y en los niños del 0% al una patología recurrente y es frecuente que se 1,37%.12 requieran diferentes tratamientos para mante- ner la enfermedad estable. 3,5,6 En España,
Load more

Recommended publications
  • Polypoid Melanoma Mistaken for Verruca Vulgaris
    THE CLINICAL PICTURE Andrea Tan, MD Daniel Gutierrez, MD Nooshin K. Brinster, MD Jennifer A. Stein, MD, PhD The Ronald O. Perelman Department of The Ronald O. Perelman Department of The Ronald O. Perelman The Ronald O. Perelman Department of Dermatology, New York University Grossman Dermatology, New York University Department of Dermatology, Dermatology, New York University Grossman School of Medicine, New York, NY; Grossman School of Medicine, New York University Grossman School of School of Medicine, New York, NY University of Texas Southwestern Medical New York, NY Medicine, New York, NY Center, Dallas, TX Polypoid melanoma mistaken for verruca vulgaris throughout the dermis (Figure 2A) • Focal epidermal contiguity with atypical melanocytes arranged in single cells and nests in the epidermis (Figure 2B) • A mitotic rate of greater than 30 mitoses/ mm2 (Figure 2C) • Lymphovascular invasion (Figure 2D) • Melanocytes highlighted by S-100 protein on immunohistochemical staining. These fi ndings were diagnostic of mela- noma, specifi cally the polypoid variant, with a tumor thickness of 5 mm. The patient was referred for wide local ex- cision with sentinel lymph node biopsy, which demonstrated inguinal node involvement and BRAF mutation on immunostaining. Positron- Figure 1. A solitary ulcerated, purple-red polypoid nodule emission tomography–computed tomography, with overlying serous crust on the lower mid-back. magnetic resonance imaging, and computed tomography of the head, chest, abdomen, and 30-year-old man presented with a pelvis were unrevealing. The formal diagnosis A 6-month history of an exophytic mass was stage IIIC disease (T4bN1M0). The pa- growing on the lower mid-back (Figure 1).
    [Show full text]
  • Spindle Cell Melanoma: Incidence and Survival, 1973‑2017
    ONCOLOGY LETTERS 16: 5091-5099, 2018 Spindle cell melanoma: Incidence and survival, 1973‑2017 ZHE XU1*, PING SHI1*, FEILUORE YIBULAYIN2,5, LEI FENG2,3, HAO ZHANG3,4 and ALIMUJIANG WUSHOU2,3 1Department of Stomatology, Shenzhen Longhua District Central Hospital, Guangdong Medical University, Shenzhen, Guangdong 518110; Departments of 2Oral and Maxillofacial Surgery, 3Oral Biomedical Engineering Laboratory, and 4Epidemiology and Biostatistics, Shanghai Stomatological Hospital, Fudan University; 5Department of Preventive Medicine, School of Public Health, Fudan University, Shanghai 200001, P.R. China Received December 2, 2017; Accepted May 11, 2018 DOI: 10.3892/ol.2018.9247 Abstract. Spindle cell melanoma (SCM) is a rare morpholog- Introduction ical subtype of melanoma, which is relatively uncharacterized. The aim of the present study was to investigate the incidence Spindle cell melanoma (SCM) is a rare subtype of malignant of SCM, its general demographics, basic clinico-pathologic melanoma composed of spindled neoplastic cells arranged in features, treatment outcomes and disease‑specific prognostic sheets and fascicles (1). The diagnosis of SCM is challenging, factors. SCM cases were sampled from the Surveillance, as SCM may occur anywhere on the body and frequently Epidemiology and End Results (SEER) Program (1973-2017). mimics amelanotic lesions, including scarring and inflam- A total of 4761 SCM cases were identified, with a median age mation (2-4). Histologically, cytologic features of SCM are of 66 years. The female:male ratio was 0.62:1. Statistically indistinct and often confused with those of other epithelial significant overall survival (OS) and disease‑specific survival neoplasms, including sarcomas and lymphomas (5-8). (DSS) rate differences were identified depending on age, sex, Immunohistochemistry is a helpful tool in distinguishing ethnicity, tumor location, T stage, N stage, M stage, patholog- SCM from other sarcomas and carcinomas (9,10).
    [Show full text]
  • The New Role of TGF-Β Superfamily Signaling in Melanoma
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2017 The new role of TGF-฀ superfamily signaling in melanoma Tuncer, Eylül Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-148195 Dissertation Published Version Originally published at: Tuncer, Eylül. The new role of TGF-฀ superfamily signaling in melanoma. 2017, University of Zurich, Faculty of Science. The New Role of TGF-β Superfamily Signaling in Melanoma Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Eylül Tuncer Aus der Türkei Promotionskommission Prof. Dr. Lukas Sommer (Leitung und Vorsitz der Dissertation) Prof. Dr. med. Onur Boyman Prof. Dr. med. Markus Manz Prof. Dr. Burkhard Becher Zürich, 2017 Table of Contents Table of Contents ......................................................................................................... 2 1. Summary .................................................................................................................. 5 2. Zusammenfassung ..................................................................................................... 6 3. Introduction .............................................................................................................. 8 3.1 Definition and Epidemiology of Cutaneous Melanoma ................................................ 8 3.2 Clinical
    [Show full text]
  • CONGRESSO NAZIONALE IMI BOLOGNA, 10-12 NOVEMBRE 2019 ROYAL HOTEL CARLTON Via Montebello, 8
    CONGRESSO NAZIONALE IMI BOLOGNA, 10-12 NOVEMBRE 2019 ROYAL HOTEL CARLTON Via Montebello, 8 rgrupp rgrupp te o te o in in m m e o o e l l n n a a a a n n i i l l o o a a m m t t i i a a ABSTRACT BOOK ABSTRACT Sommario ABSTRACT AREA EPIDEMIOLOGIA GENETICA E PATOGENESI .............................................................................................................................................................................. 4 Two pathways of nevus associated melanoma: clinical and dermoscopic characteristics ..................................................................................................................................... 4 Vitamin D and disease free survival in stage II melanoma ..................................................................................................................................................................................... 5 Progetto IMI Tele-consulenza genetica (TG): utilizzo di strumenti di telemedicina per consulenza genetica e test molecolare di predisposizione al melanoma. Risultati preliminari. ............................................................................................................................................................................................................................................................. 7 Mutation screening at germline and somatic levels in patients with multiple primary melanomas ..................................................................................................................... 8 Caratterizzazione
    [Show full text]
  • Utility of Endoscopic Trans-Bronchial Needle Aspiration, Coupled With
    Lio E, et al., J Case Repo Imag 4: 029. Journal of Case Reports & Imaging Case Report Utility of Endoscopic Trans-Bronchial Needle Aspiration, Coupled With Rapid On-Site Evaluation (Without EBUS), In the Diagnosis of Thoracic Metastasis of Polypoid Melanoma: A Case Report Elena Lio, Corrado Pelaia, Achille Gaudio, Giuseppina Marrazzo and Girolamo Pelaia* Department of Health Sciences, Magna Græcia University, Catanzaro, Italy Abstract *Corresponding author: Girolamo Pelaia, Department of Health Sciences, Magna Græcia University, Catanzaro, Italy, Tel: +39 09613647171; E-mail: pelaia@unicz.it Whenever an adequate diagnostic material is available, Rapid Received Date: December 04, 2020 On-Site Evaluation (ROSE) has proven to be an important, easy and cost-effective adjunct in the diagnosis of thoracic lesions, so that for Accepted Date: December 15, 2020 example cytology may even outperform histology in diagnosis of Published Date: December 22, 2020 lung cancer. Our team applied ROSE on a sample obtained through Trans-Bronchial Needle Aspiration (TBNA), which can be useful Citation: Lio E, Pelaia C, Gaudio A, Marrazzo G, Pelaia G (2020) Utility of Endo- for diagnosis of thoracic metastasis. In the present case report the scopic Trans-Bronchial Needle Aspiration, Coupled With Rapid On-Site Evaluation primitive tumor was a polypoid melanoma, which had been excised in (Without EBUS), In the Diagnosis of Thoracic Metastasis of Polypoid Melanoma: A Case Report. J Case Repo Imag 4: 029. 2013. We performed ROSE coupled with TBNA without the support of Endobronchial Ultrasound (EBUS), thus succeeding in confirming Copyright: © 2020 Lio E, et al. This is an open-access article distributed under the the diagnosis of polypoid melanoma metastasis, suspected on the terms of the Creative Commons Attribution License, which permits unrestricted use, basis of patient medical history.
    [Show full text]
  • Polypoid Melanoma Mistaken for Verruca Vulgaris
    THE CLINICAL PICTURE Andrea Tan, MD Daniel Gutierrez, MD Nooshin K. Brinster, MD Jennifer A. Stein, MD, PhD The Ronald O. Perelman Department of The Ronald O. Perelman Department of The Ronald O. Perelman The Ronald O. Perelman Department of Dermatology, New York University Grossman Dermatology, New York University Department of Dermatology, Dermatology, New York University Grossman School of Medicine, New York, NY; Grossman School of Medicine, New York University Grossman School of School of Medicine, New York, NY University of Texas Southwestern Medical New York, NY Medicine, New York, NY Center, Dallas, TX Polypoid melanoma mistaken for verruca vulgaris throughout the dermis (Figure 2A) • Focal epidermal contiguity with atypical melanocytes arranged in single cells and nests in the epidermis (Figure 2B) • A mitotic rate of greater than 30 mitoses/ mm2 (Figure 2C) • Lymphovascular invasion (Figure 2D) • Melanocytes highlighted by S-100 protein on immunohistochemical staining. These fi ndings were diagnostic of mela- noma, specifi cally the polypoid variant, with a tumor thickness of 5 mm. The patient was referred for wide local ex- cision with sentinel lymph node biopsy, which demonstrated inguinal node involvement and BRAF mutation on immunostaining. Positron- Figure 1. A solitary ulcerated, purple-red polypoid nodule emission tomography–computed tomography, with overlying serous crust on the lower mid-back. magnetic resonance imaging, and computed tomography of the head, chest, abdomen, and 30-year-old man presented with a pelvis were unrevealing. The formal diagnosis A 6-month history of an exophytic mass was stage IIIC disease (T4bN1M0). The pa- growing on the lower mid-back (Figure 1).
    [Show full text]
  • Review Article from Melanocyte to Metastatic Malignant Melanoma
    Hindawi Publishing Corporation Dermatology Research and Practice Volume 2010, Article ID 583748, 8 pages doi:10.1155/2010/583748 Review Article From Melanocyte to Metastatic Malignant Melanoma Bizhan Bandarchi,1 Linglei Ma,2 Roya Navab,1 Arun Seth,3 and Golnar Rasty4 1 Department of Applied Molecular Oncology, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, 7 Yorkview Drive, Toronto, ON, Canada M2N 2R9 2 Department of Pathology, University of Michigan Hospital, University of Michigan, Michigan 48109-0602, USA 3 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada M4N 3M5 4 Department of Laboratory Medicine and Pathobiology, University Health Network, University of Toronto, Toronto, Canada M5G 2C4 Correspondence should be addressed to Bizhan Bandarchi, bizhanb@yahoo.com Received 10 January 2010; Revised 22 April 2010; Accepted 15 July 2010 Academic Editor: Prashiela Manga Copyright © 2010 Bizhan Bandarchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Malignant melanoma is one of the most aggressive malignancies in human and is responsible for almost 60% of lethal skin tumors. Its incidence has been increasing in white population in the past two decades. There is a complex interaction of environmental (exogenous) and endogenous, including genetic, risk factors in developing malignant melanoma. 8–12% of familial melanomas occur in a familial setting related to mutation of the CDKN2A gene that encodes p16. The aim of this is to briefly review the microanatomy and physiology of the melanocytes, epidemiology, risk factors, clinical presentation, historical classification and histopathology and, more in details, the most recent discoveries in biology and genetics of malignant melanoma.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,149,455 B2 Desai Et Al
    US0091494.55B2 (12) United States Patent (10) Patent No.: US 9,149,455 B2 Desai et al. (45) Date of Patent: Oct. 6, 2015 (54) METHODS OF TREATING MELANOMA I6/22 (2013.01); C07K 16/2818 (2013.01); C07K 16/3053 (2013.01); A61K 2039/505 (71) Applicant: Abraxis BioScience, LLC, Los Angeles, (2013.01) CA (US) (58) Field of Classification Search CPC. A61 K31/337; A61 K9/0019; A61 K9/5169 (72) Inventors: Neil P. Desai, Los Angeles, CA (US); See application file for complete search history. Markus Renschler, San Francisco, CA (US) (56) References Cited (73) Assignee: ABRAXIS BIOSCIENCE, LLC, Los U.S. PATENT DOCUMENTS Angeles, CA (US) 5,362.478 A 11, 1994 Desai et al. (*) Notice: Subject to any disclaimer, the term of this tes A 32 CREF, al. patent is extended or adjusted under 35 5,505,932 A 4/1996 Grinstaffet al. U.S.C. 154(b) by 32 days. 5,508,021 A 4/1996 Grinstaffet al. 5,512,268 A 4/1996 Grinstaffet al. (21) Appl. No.: 13/791,841 5,560,933 A 10/1996 Soon-Shiong et al. (Continued) (22) Filed: Mar. 8, 2013 FOREIGN PATENT DOCUMENTS (65) Prior Publication Data WO WO94, 18954 A1 9, 1994 US 2014/01342.57 A1 May 15, 2014 WO WO 98,14174 A1 4f1998 Related U.S. Application Data (Continued) (60) Provisional application No. 61/724,892, filed on Nov. OTHER PUBLICATIONS 9, 2012, provisional application No. 61/763,391, filed Sietal, “Prevalence of BRAFV600E Mutation in Chinese Melanoma on Feb. 11, 2013.
    [Show full text]
  • From Melanocyte to Malignant Metastatic Melanoma
    Dermatology Research and Practice From Melanocyte to Malignant Metastatic Melanoma Guest Editors: Prashiela Manga, Keith S. Hoek, Lester M. Davids, and Sancy A. Leachman From Melanocyte to Malignant Metastatic Melanoma Dermatology Research and Practice From Melanocyte to Malignant Metastatic Melanoma Guest Editors: Prashiela Manga, Keith S. Hoek, Lester M. Davids, and Sancy A. Leachman Copyright © 2010 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in volume 2010 of “Dermatology Research and Practice.” All articles are open access articles dis- tributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Dermatology Research and Practice Editorial Board Dietrich Abeck, Germany Salvador Gonzalez,˜ USA Gavin P. Robertson, USA Christoph Abels, Germany Jane Grant-Kels, USA Franco Rongioletti, Italy Giuseppe Argenziano, Italy Joan Guitart, USA Stefano Rosso, Italy Jorge Arrese, Belgium Takashi Hashimoto, Japan Toshiaki Saida, Japan Khusru Asadullah, Germany Jana Hercogova,´ Czech Republic Mario Santinami, Italy Robert Baran, France Herbert Hoenigsmann, Austria Tadamichi Shimizu, Japan Wilma Fowler Bergfeld, USA D. Jukic,´ USA Bruce Robert Smoller, USA BrunoA.Bernard,France Hideko Kamino, USA Hans Peter Soyer, Australia Jag Bhawan, USA D. V. Kazakov, Czech Republic Giuseppe Stinco, Italy Craig G. Burkhart, USA Lajos Kemeny, Hungary Markus Stucker,¨ Germany Andrea Cavani, Italy Elizabeth Helen Kemp, UK Desmond J. Tobin, UK Eung-Ho Choi, Republic of Korea Kaoru Kiguchi, USA Franz Trautinger, Austria Enno Christophers, Germany Yasuo Kitajima, Japan Uwe Trefzer, Germany Clay Cockerell, USA Rossitza Lazova, USA Helgi Valdimarsson, Iceland I. Kelman Cohen, USA Philip E. LeBoit, USA Vladimir Vincek, USA Philip J.
    [Show full text]
  • In Vitroand in Vivostudies of a Novel Blood Brain Barrier Permeabilizing
    In vitro and in vivo studies of a novel blood brain barrier permeabilizing peptide K16ApoE And novel in vivo treatment of melanoma brain metastases Christopher Florian Holte This thesis is submitted in partial fulfilment of the requirements for the degree of Master in Medical Biology – Biomedical Image Sciences Department of Biomedicine University of Bergen 2016 Table of Contents Acknowledgements .................................................................................................................. 4 Abbreviations .......................................................................................................................... 5 Table of figures ....................................................................................................................... 7 Abstract .................................................................................................................................. 9 1 Introduction .........................................................................................................................12 1.1 Skin cancer and melanoma .................................................................................................12 1.2 Incidence and causes of melanoma ......................................................................................13 1.3 Mutations in melanoma development ...................................................................................15 1.4 Grading and staging of melanoma ........................................................................................15
    [Show full text]
  • Polypoid Anal Melanoma. a Case Report and Review of the Literature Ann
    Digital Edition e-publish on-line ISSN 2239-253X Polypoid anal melanoma. A case report and review of the literature Ann. Ital. Chir., 87, 5, 2016: 1-6 Published online (EP) 12 November 2016 PII: S2239253X16026207 www.annitalchir.com Roberta Tutino*/**, Giuseppe Clerico**, Alberto Realis Luc**, Gaetano Gallo***/**, Mario Trompetto** *Department of Surgical, Oncological and Oral Sciences, University of Palermo, General Surgery and Emergency O.U., Policlinico Universitario “P. Giaccone”, Palermo, Italy **Coloproctology O.U., Clinica Santa Rita, Policlinico di Monza, Vercelli, Italy ***Department of General Surgery, University of Catanzaro, Italy Polypoid anal melanoma. A case report and review of the literatureCOPY INTRODUCTION: Ano-rectal melanoma is an uncommon finding in patients complaining of rectal bleeding and/or anal mass often misinterpreted as a haemorroidal pile. CASE REPORT: A 55-years-old woman, complaining of rectal bleeding, frequent anal pain and anal mass suspected for haemorroidal thrombosis was referred for evaluation and possible treatment. A brown polypoid mass arising from the anal canal/lower rectum with a maximum diameter of 6 cm was diagnosed. The hystological examination of the neo- plasm, transanally removed, revealed the presence of a polypoid melanoma partially involving the resection margin. Nor metastases nor limph-node involvement were found at the total-body CT scan and at a CT-PET. C-KIT examination was negative. Multidisciplinary evaluation recommended an abdominoperineal resection followed by an adjuvant chemother- apy as the only possible salvage treatment. To date the patient has refused it. DISCUSSION: The delay in the diagnosis of an anal melanoma is PROHIBITEDwell-known, bringing frequently to treat advanced stages of the disease that to date has no clear guidelines for the treatment.
    [Show full text]
  • Histological Types of Polypoid Cutaneous Melanoma II
    Coll. Antropol. 31 (2007) 4: 1049–1053 Original scientific paper Histological Types of Polypoid Cutaneous Melanoma II Fabijan Kne`evi}1, Vjekoslav Duan~i}2, Sanda [iti}1, Anica Horvat-Kne`evi}3, Vesna Benkovi}3, Snje`ana Rami}1, Kre{imir Kostovi}4, Vesna Ramljak5, Danko Velemir Vrdoljak6, Mladen Stanec6 and Angelina Bo`ovi}7 1 Department of Clinical Pathology, University Hospital for Tumors, Zagreb, Croatia 2 Institute for Cardiovascular Prevention and Rehabilitation, Zagreb, Croatia 3 Department of Animal Physiology, Faculty of Science, University of Zagreb, Zagreb, Croatia 4 Department of Dermatovenerology, University Hospital »Zagreb«, School of Medicine, University of Zagreb, Zagreb, Croatia 5 Department of Clinical Cytology, University Hospital for Tumors, Zagreb, Croatia 6 Department of Surgical Oncology, University Hospital for Tumors, Zagreb, Croatia 7 Midwifering and Nursing School, Zagreb, Croatia ABSTRACT The aim of this study was to ascertain which histological types of melanoma can clinically and morphologically ap- pear as polypoid melanomas. In 645 cases of primary cutaneous melanoma we have analyzed criteria for diagnosis of polypoid cutaneous melanoma and afterwards we have analyzed growth phase in each polypoid melanoma, histological type of atypical melanocytes, the number of epidermal ridges which are occupied by atypical melanocytes, and distribu- tion according to age, sex and location, as well as the disease free survival. According to the criteria for polypoid melano- mas we have found 147 (22.8%) polypoid cutaneous melanomas. Analyzing the growth phases, histological types of atypi- cal melanocytes and the number of affected epidermal ridges in the group of polypoid melanomas we have ascertained 2 (1.4%) ALMs, 4 (2.8%) LMMs, 42 (28.6%) SSMs and 99 (67.2%) NMs.
    [Show full text]